Investigation of the Response Relationship of NN5401 in Type 1 Diabetics

NCT00993096 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: insulin degludec/insulin aspart
DRUG: insulin degludec/insulin aspart
DRUG: insulin degludec/insulin aspart
DRUG: biphasic insulin aspart 30
DRUG: biphasic insulin aspart 30
DRUG: biphasic insulin aspart 30

Sponsor

Novo Nordisk A/S